An overview on a novel adjuvanted prophylactic hepatitis B vaccine.
Thoelen
S
S
SmithKline Beecham Biologicals, Rixensart, Belgium.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D014481:United States
D000276:Adjuvants, Immunologic; D017325:Hepatitis B Vaccines